Clinical trial
A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency
NCT00232973 is registered in ClinicalTrials.gov with Intercytex as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency
- Lead sponsor
- Intercytex
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2005
- Completion date
- Not reported
- Enrollment
- 396 (estimated)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.